Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
Crossref DOI link: https://doi.org/10.1186/s13075-015-0797-9
Published Online: 2015-10-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gow, Jason M.
Tsuji, Wayne H.
Williams, Gary J.
Mytych, Daniel
Sciberras, David
Searle, Shawn L.
Mant, Tim
Gibbs, John P.